SYRE News
Spyre Therapeutics, Inc.
$78.63
-$1.82(-2.26%)
33
Overall
60
Value
20
Tech
21
Quality
Market Cap
$7.09B
Volume
1.62M
52W Range
$18.12 - $110.18
Target Price
$118.60
SYRE news: the latest Spyre Therapeutics, Inc. headlines, press releases and market updates, newest first.
Latest SYRE News
- Spyre Therapeutics (SYRE) Receives a Buy from UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 11, 2026
- Wells Fargo Reaffirms Their Buy Rating on Spyre Therapeutics (SYRE)TipRanks Auto-Generated Intelligence Newsdesk · Oct 3, 2026
- Newegg, Medpace, Compass, Spyre, MINISO Insider Shake-UpTipRanks Weekend Auto-Generated Newsdesk · Oct 3, 2026
- Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)TipRanks Newsroom · Sep 27, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $78.63 | -2.3% | 1.62M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Spyre Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW